Palladium(II)-catalyzed alkoxylation of unactivated C(sp³)–H bonds using hypervalent iodine(III) reagents has emerged as a powerful strategy for the direct functionalization of inert carbon–hydrogen bonds. Despite significant advances in this area, the mechanistic details governing these transformations remain elusive. This study presents a comprehensive density functional theory (DFT) investigation into the alkoxylation of butyramide derivatives, revealing an unprecedented reaction pathway that challenges long-standing assumptions in the literature. Our computational analysis demonstrates that the previously proposed mechanism involving sequential oxidative addition and ligand exchange is inconsistent with experimental observations. Instead, we uncover a novel four-step mechanism: C(sp³)–H activation via the concerted metallation–deprotonation (CMD) pathway, followed by oxidative addition initiated by X-ligand transfer from the iodine(III) reagent to Pd(II), reductive elimination through an outer-sphere SN2 process, and catalyst regeneration.
The catalytic cycle begins with the coordination of the substrate to Pd(OAc)₂, followed by OAc-assisted deprotonation of both the N–H and C(sp³)–H bonds via the CMD mechanism. The resulting cyclopalladated intermediate undergoes substitution by the cyclic iodine(III) reagent, methoxybenziodoxole (BI–OMe), forming a key adduct.DDX58 Antibody manufacturer Crucially, our calculations show that oxidative addition does not proceed through direct insertion but instead involves the transfer of the methoxy ligand from iodine(III) to palladium, generating a square pyramidal iodonium complex. This step is facilitated by a low-energy isomerization in which the quinoline moiety migrates from a basal to an apical position, triggering electron transfer from Pd(II) to iodine(III). This redox event leads to formal oxidation of palladium to Pd(IV), accompanied by cleavage of the I–O bond and release of a free carboxylate anion. The resulting Pd(IV) species is highly reactive and readily undergoes C–O reductive elimination.
Notably, the reductive elimination occurs via an outer-sphere nucleophilic attack by the solvent alcohol on the sp³ carbon, assisted by the pendant carboxylate anion. This mechanism explains why the methoxy group from the oxidant remains spectator-like and does not appear in the product—only the solvent alcohol contributes the alkoxy group.Loricrin Antibody supplier Furthermore, when non-alcoholic solvents are used, such as DCE, the reaction shifts toward carboxylation due to the absence of a nucleophilic alcohol, supporting the role of solvent in directing selectivity.PMID:35205752 The high activation barrier observed experimentally is attributed to the endergonic regeneration of the active catalyst, which forms a stable tridentate complex with the alkoxylated product, thereby requiring elevated temperatures to overcome kinetic limitations.
Our findings also reveal that the reaction mechanism can vary depending on the electronic nature of the substrate. For substrates bearing electron-donating groups like OMe, the formation of a Pd(IV) intermediate is avoided altogether. Instead, a zwitterionic transition state forms directly after ligand transfer, enabling a fast, barrierless C–O coupling via nucleophilic addition to an oxonium ion. This switch in mechanism underscores the versatility and tunability of Pd(II)/iodine(III) systems. Moreover, the generality of this mechanism is validated by applying similar DFT analysis to a related system using PIDA as the oxidant, confirming identical mechanistic features.
In conclusion, this work provides a fundamentally new understanding of Pd(II)-catalyzed alkoxylation reactions mediated by hypervalent iodine(III) reagents. By elucidating the true pathway—centered on ligand transfer, isomerization-driven redox chemistry, and outer-sphere reductive elimination—it offers critical insights for rational catalyst design and the development of new C–H functionalization methods. These results highlight the importance of revisiting established mechanisms through advanced computational tools and pave the way for more efficient and selective transformations in synthetic chemistry.MedChemExpress (MCE) offers a wide range of high-quality research chemicals and biochemicals (novel life-science reagents, reference compounds and natural compounds) for scientific use. We have professionally experienced and friendly staff to meet your needs. We are a competent and trustworthy partner for your research and scientific projects.Related websites: https://www.medchemexpress.com